Market Overview:
The global cervical dysplasia market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of cervical cancer, rising awareness about cervical dysplasia and its diagnosis, and technological advancements in diagnostic devices. The global cervical dysplasia market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into diagnostic tests and diagnostic devices. and others). On the basis of application, the market is divided into hospitals, diagnostics centers ambulatory surgical centers private gynecologist’s offices among others.
Product Definition:
Cervical dysplasia is a pre-cancerous lesion of the cervix. It is caused by the abnormal growth of cells on the surface of the cervix. These cells may become cancerous if left untreated. Cervical dysplasia can be detected through a Pap smear, which is a test that screens for cervical cancer.
Diagnostic Test:
Diagnostic test is used for detection of abnormal cell growth in the cervix. Abnormal cell growth can be due to infection, inflammation or cancer. Diagnostic tests are done by medical laboratory techniques which include Pap test and HPV (human papillomavirus) testing. These tests also determine the stage of cervical cancer which includes cytology test, colposcopy & cystoscopy and endocervical biopsy.
Diagnostic Devcie:
A diagnostic device is a medical instrument used for the detection of disease or determining the nature of a health problem. It can be either portable or non-portable depending on its application and type. A diagnostic device comprises various tests, devices, and equipment that are used to detect diseases in patients by analyzing body fluids such as urine, blood, sweat etc.
Application Insights:
Based on application, the global market is segmented into hospitals, diagnostic centers, ambulatory surgical centers and private gynecologist offices. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at a large scale. Furthermore, presence of highly skilled medical personnel and dedicated diagnostics departments contribute towards larger shareholding by hospitals in the overall market. Cervical cancer leads to high demand for cervical screening programs which further drives growth of this segment during forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of this disease, increasing awareness about early diagnosis, availability of effective treatment modalities and presence of well-established healthcare facilities in this region. Moreover, growing number of government initiatives and programs targeting women population is expected to further fuel the growth during the forecast period. For instance, National Cervical Cancer Awareness Month (NCCAM) promotes awareness about cervical cancer prevention through education campaigns that focus on women aged 25 years and younger throughout North America every year from March 2018.
Asia Pacific is anticipated to witness lucrative growth over a projected period owing to rising incidence rate due to lack of proper screening programs for women population in countries such as India and China despite being aware about its causes & symptoms as well as available treatments options at par with developed regions worldwide’s leading experts have stated that there is a need for developing nations such as India & China & Japan etc.
Growth Factors:
- Rising incidence of cervical cancer due to changing lifestyle and growing population
- Increasing awareness about the disease and its early detection methods
- Growing demand for minimally invasive procedures for cervical dysplasia treatment
- Technological advancements in diagnosis and treatment of the disease
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Cervical Dysplasia Market Research Report
By Type
Diagnostic Test, Diagnostic Devcie
By Application
Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Private Gynecologist’s Offices
By Companies
Becton Dickinson, Hologic, Micromedic, OncoHealth, Quest Diagnostics, Roche, QIAGEN, Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Cervical Dysplasia Market Report Segments:
The global Cervical Dysplasia market is segmented on the basis of:
Types
Diagnostic Test, Diagnostic Devcie
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Private Gynecologist’s Offices
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton Dickinson
- Hologic
- Micromedic
- OncoHealth
- Quest Diagnostics
- Roche
- QIAGEN
- Abbott Laboratories
Highlights of The Cervical Dysplasia Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diagnostic Test
- Diagnostic Devcie
- By Application:
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Private Gynecologist’s Offices
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cervical Dysplasia Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cervical dysplasia is a condition in which the cells that make up the cervical tissue (the lining of the uterus) become abnormal. This can cause problems with fertility, including difficulty getting pregnant and carrying a baby to term.
Some of the major players in the cervical dysplasia market are Becton Dickinson, Hologic, Micromedic, OncoHealth, Quest Diagnostics, Roche, QIAGEN, Abbott Laboratories.
The cervical dysplasia market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cervical Dysplasia Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cervical Dysplasia Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cervical Dysplasia Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cervical Dysplasia Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cervical Dysplasia Market Size & Forecast, 2020-2028
4.5.1 Cervical Dysplasia Market Size and Y-o-Y Growth
4.5.2 Cervical Dysplasia Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Diagnostic Test
5.2.2 Diagnostic Devcie
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers
6.2.3 Ambulatory Surgical Centers
6.2.4 Private Gynecologist’s Offices
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cervical Dysplasia Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cervical Dysplasia Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Diagnostic Test
9.6.2 Diagnostic Devcie
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers
9.10.3 Ambulatory Surgical Centers
9.10.4 Private Gynecologist’s Offices
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Diagnostic Test
10.6.2 Diagnostic Devcie
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers
10.10.3 Ambulatory Surgical Centers
10.10.4 Private Gynecologist’s Offices
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Diagnostic Test
11.6.2 Diagnostic Devcie
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers
11.10.3 Ambulatory Surgical Centers
11.10.4 Private Gynecologist’s Offices
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Diagnostic Test
12.6.2 Diagnostic Devcie
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers
12.10.3 Ambulatory Surgical Centers
12.10.4 Private Gynecologist’s Offices
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Diagnostic Test
13.6.2 Diagnostic Devcie
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers
13.10.3 Ambulatory Surgical Centers
13.10.4 Private Gynecologist’s Offices
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cervical Dysplasia Market: Competitive Dashboard
14.2 Global Cervical Dysplasia Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton Dickinson
14.3.2 Hologic
14.3.3 Micromedic
14.3.4 OncoHealth
14.3.5 Quest Diagnostics
14.3.6 Roche
14.3.7 QIAGEN
14.3.8 Abbott Laboratories
